This month our current President, Teun van Gelder, shares his vision for his term, in particular increasing involvement of prescribers with the activities of the Association and research in the field. We also hear about Teun’s dual role at the Erasmus Medical Centre, and the collaboration between several prominent IATDMCT members that bring together various disciplines to daily patient care.

Teun van Gelder
Internist-nephrologist, Department of Internal Medicine
Internist-clinical pharmacologist, Hospital Pharmacy Department
Erasmus Medical Center, Rotterdam, NL

This month we hear from our recent Past-President, Loralie Langman, who shares with us a few reflections about her time as President, her passion for the field and a few innovative technologies used in her place of practice, spanning clinical and forensic toxicology, TDM, and pharmacogenetics.

Loralie Langman
Director, Department of Laboratory Medicine and Pathology
Mayo Clinic, Rochester, MN, USA

This month we return to our interviews, and hear from Professor William Clarke, Chair of the TDM in Oncology committee. Alongside academic and clinical work, Professor Clarke is involved in an academic initiative in disposable microfluidic diagnostics, which has potential to impact the clinical application of TDM in resource limited settings.

William Clarke
Associate Professor, Pathology
Johns Hopkins School of Medicine, Baltimore, Maryland, USA

IATDMCT Blog: September Compass Highlight - A Personal Reflection from Professor Michael Oellerich

This month we bring to you a highlight from the IATDMCT September Compass. Professor Michael Oellerich is going to step down from his position of Editor-in-Chief of the Therapeutic Drug Monitoring journal.

We would like to acknowledge Professor Oellerich for his work and long record of success in leading the journal.

Personal Reflection
By Professor Michael Oellerich
Georg-August-University
Goettingen, Germany